The FDA ended the official tirzepatide shortage, which restricts the legal basis for 503A pharmacies to compound it
Underlying conditions such as hypothyroidism, Cushing's syndrome, PCOS, or obstructive sleep apnoea can blunt weight loss responses and should be investigated if not already excluded
together, they can improve body composition, cardiovascular health, and emotional well-being
Pattern 2: gradual gain of 1 to 2 pounds per week over 4 or more weeks Most likely cause: Calorie creep plus metabolic adaptation
The activity of Foxo proteins is negatively regulated by the PI3K/Akt signaling pathway
QMP engineering prolongs the ability of the GLP-1 albumin fusion to restrict glycemic excursion in vivo To investigate whether the GLP-1 albumin fusions would stimulate insulin secretion in vivo, we performed a glucose tolerance test (GTT) in human FcRn Tg32 mice (Fig